Purpose
Compliant version of the Adult Immunization Schedule by Age
Ages 19 Years or Older
< < Back to Adult Immunization Schedule by Age Group
¶ = Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of immunity
§ = Recommended vaccination for adults with an additional risk factor or another indication
± = Recommended vaccination based on shared clinical decision-making
⇒ = No recommendation/Not applicable
| Vaccine | 19-26 years | 27-49 years | 50-64 years | ≥65 years | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19  |
1 or more doses of updated (2023-2024 Formula) vaccine (See notes)¶ | ||||||||||||
| Influenza inactivated (IIV4) or Influenza recombinant (RIV4) |
¶ | 1 dose annually¶ | ¶ | ¶ | |||||||||
| Influenza live attenuated (LAIV4) |
¶ |  1 dose annually¶ |
⇒ | ⇒ | |||||||||
| Respiratory Syncytial Virus (RSV) |
Seasonal administration during pregnancy. (See notes)§ | ⇒ | ⇒ | ⇒ | ± | ≥60 years± | |||||||
| Tetanus, diphtheria, pertussis (Tdap or Td) |
1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (See notes)§ | ||||||||||||
| 1 dose Tdap, then Td or Tdap booster every 10 years¶ | |||||||||||||
| Measles, mumps, rubella (MMR) |
1 or 2 doses depending on indication (if born in 1957 or later)¶ |
For healthcare personnel, (See notes)⇒ |
|||||||||||
| Varicella (VAR) |
2 doses (if born in 1980 or later)¶ |
¶ | § | 2 doses§ | |||||||||
| Zoster recombinant (RZV) |
2 doses for immunocompromising conditions (See notes)§ | 2 doses¶ | |||||||||||
| Human papillomavirus (HPV) |
2 or 3 doses depending on age at initial vaccination or condition¶ | 27 through 45 years± | ± | ⇒ | ⇒ | ⇒ | |||||||
| Pneumococcal (PCV15, PCV20, PPSV23) |
§ | See Notes¶ | |||||||||||
| See Notes± | |||||||||||||
| Hepatitis A (HepA) |
2, 3, or 4 doses depending on vaccine§ | ||||||||||||
| Hepatitis B (HepB) |
2, 3, or 4 doses depending on vaccine or¶ | condition§ | |||||||||||
| Meningococcal A, C, W, Y (MenACWY) |
1 or 2 doses depending on indication, See notes for booster recommendations§ | ||||||||||||
| Meningococcal B (MenB) |
2 or 3 doses depending on vaccine and indication, See notes for booster recommendations§ | ||||||||||||
| 19 through 23 years± | § | ||||||||||||
| Haemophilus influenzae type b (Hib) |
1 or 3 doses depending on indication§ | ||||||||||||
| Mpox |
§ | ||||||||||||
Content Source:
National Center for Immunization and Respiratory Diseases